INTERNATIONAL PATENT: LENTIGEN TECHNOLOGY, INC. FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR TREATING CANCER WITH IL7FC ARMORED CAR-T CELLS"

GENEVA, Jan. 7 -- LENTIGEN TECHNOLOGY, INC. (1201 Clopper RoadGaithersburg, Maryland 20878) filed a patent application (PCT/US2025/035624) for "CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR TREATING CANCER WITH IL7FC ARMORED CAR-T CELLS" on Jun 27, 2025. With publication no. WO/2026/006682, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEY, Soumyadeep (13207 Windsong LaneClarksburg, Maryland 20871), ZHU, Zhongyu (2501 Carrington WayFrederick, Maryland 21702), XIE, Yanping (13512 Hayworth DrivePotomac, Maryland 20854), VU, Ban...